Media Library
-
ImagelockLocations / ImageView from “Hohlweg” passing under the Novartis Pavillon
View from “Hohlweg” passing under the Novartis Pavillon -
ImagelockLocations / ImageView of the Novartis Pavillon towards Dreirosenbrücke and city center
View of the Novartis Pavillon towards Dreirosenbrücke and city center -
ImagelockLocations / ImageView from Kleinbasel towards Novartis Campus Basel
View from Kleinbasel towards Novartis Campus Basel -
ImagelockLocations / ImageBird's eye view, Novartis Pavillon
Bird's eye view, Novartis Pavillon -
ImagelockLocations / ImageMain entrance, Novartis Pavillon
Main entrance, Novartis Pavillon -
ImagelockLeadership / ImageJohn D. Young
Board member since March 2023 -
PDFlockPublications / ReportNovartis in Society Integrierter Geschäftsbericht 2022
The Novartis in Society Integrated Report covers our business, strategy and performance. It highlights progress against our ESG targets and describes how we create value for diverse stakeholders. This is the German version of the report. -
ImagelockLocations / ImageManufacturing RNA therapies in Schweizerhalle, Switzerland
Manufacturing RNA therapies in Schweizerhalle, Switzerland -
ImagelockLocations / ImageView of RNA production in Schweizerhalle, Switzerland
View of RNA production in Schweizerhalle, Switzerland -
ImagelockLocations / ImageProduction process of RNA therapies in Schweizerhalle, Switzerland
Production process of RNA therapies in Schweizerhalle, Switzerland -
PDFlockFact Sheet52-week results for Cosentyx® in hidradenitis suppurativa: A summary
Discover the data published in The Lancet on the long-term effect of Cosentyx® (secukinumab) in adults with hidradenitis suppurativa from the SUNRISE and SUNSHINE trials. -
PDFlockPublications / ReportNovartis in Society Integrated Report 2022
The Novartis in Society Integrated Report covers our business, strategy and performance. It highlights progress against our ESG targets and describes how we create value for diverse stakeholders.